BIOCANCELL THERAPEUTICS INC. Debt Conversion, Converted Instrument, Amount
BIOCANCELL THERAPEUTICS INC. reported Debt Conversion, Converted Instrument, Amount of $360.00 thousand for the 90-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2012-05-10
- BIOCANCELL THERAPEUTICS INC. debt conversion, converted instrument, amount for the quarter ending 2012-03-31 was $0.00.
- BIOCANCELL THERAPEUTICS INC. debt conversion, converted instrument, amount for the quarter ending 2011-12-31 was $0.00.
- BIOCANCELL THERAPEUTICS INC. debt conversion, converted instrument, amount for the quarter ending 2011-09-30 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 81 month | Debt Conversion, Converted Instrument, Amount 84 month | Debt Conversion, Converted Instrument, Amount 87 month | Debt Conversion, Converted Instrument, Amount 90 month |
|---|---|---|---|---|---|---|---|
| 2012-03-31 | $0.00 derived: 10-Q 90 month − 10-K 87 month · filed 2012-05-10 | $0.00 derived: sum of 2 quarters · filed 2012-05-10 | $0.00 derived: sum of 3 quarters · filed 2012-05-10 | $360.00K 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | $0.00 derived: 10-K 87 month − 10-Q 84 month · filed 2012-03-30 | $0.00 derived: sum of 2 quarters · filed 2012-03-30 | $360.00K 10-K · filed 2012-03-30 | ||||
| 2011-09-30 | $0.00 derived: 10-Q 84 month − 10-Q/A 81 month · filed 2011-11-07 | $360.00K 10-Q · filed 2011-11-07 | |||||
| 2011-06-30 | $360.00K 10-Q/A · filed 2011-08-30 |